Generate a tailored SOP for Dr. David Owen. Improve your application with a focused, well-structured draft.
David Owen is a clinical pharmacologist and the Campus Director at Hammersmith Hospital. He serves as the Head of Clinical Studies at the NIHR Imperial Clinical Research Facility (ICRF), which facilitates clinical trials and experimental medicine studies aimed at translating laboratory discoveries into future medications. His research program focuses on utilizing both clinical and basic science studies to investigate the mitochondrial 18kDa Translocator Protein (TSPO). His prior experience includes roles as a PhD student and postdoctoral researcher concentrated on pharmacology and TSPO PET imaging targets. Currently, Owen is examining drug targets related to CNS (neurodegeneration) and non-CNS (pulmonary vascular disease) conditions, with initial funding from the MRC Clinician Scientist Fellowship and the BHF Senior Clinical Fellowship. Additionally, he dedicates approximately 20% of his time to clinical medicine, attending to acute medical patients, leading pharmacology teaching at Imperial Medical School, directing the MRes in Clinical Research, and contributing to several committees regarding medication use, including chairing the North West London Integrated Formulary Committee that influences prescribing for 2.6 million individuals, as well as the Subregional IVIG committee focusing on the stewardship of this critical resource among six NHS Trusts.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.